Pooja Shah

Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation

Xingyue He, J. Newcomb, J. Brownell, 2015, PloS one.

Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6tx00220j

L. Dick, F. Wolenski, V. Csizmadia, 2016, Toxicology research.

Proteasome inhibitors bortezomib and car fi lzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA 2 / Omi †

L. Dick, F. Wolenski, V. Csizmadia, 2016 .

Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.

Pooja Shah, Hua Liao, John Newcomb, 2017, Nature chemical biology.

Identification of a lung cancer cell line deficient in atg7-dependent autophagy.

J. Brownell, Hugues Bernard, O. Tayber, 2015, Autophagy.

A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models

Steven S. Langston, Xingyue He, E. Lightcap, 2021, Science Translational Medicine.

Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage

Pooja Shah, Hugues Bernard, T. Shinozawa, 2016, Journal of applied toxicology : JAT.